Furthermore, Jie et al. showed that the abnormally high expression of KDM4C in lung cancer inhibits CXCL10 transcription by reducing the enrichment of H3K36me3 at the CXCL10 promoter region [49]. The gene discussed is KDM4C; the disease is lung cancer.